California Public Employees Retirement System’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-29,400
Closed -$1.1M 2548
2021
Q1
$1.1M Sell
29,400
-2,724
-8% -$114K ﹤0.01% 2425
2020
Q4
$1.07M Sell
32,124
-600
-2% -$24.3K ﹤0.01% 2429
2020
Q3
$1.2M Buy
32,724
+800
+3% +$27.7K ﹤0.01% 2145
2020
Q2
$1.05M Buy
31,924
+23,916
+299% +$919K ﹤0.01% 2205
2020
Q1
$207K Buy
+8,008
New +$268K ﹤0.01% 2838

Other funds holding PHAT

California Public Employees Retirement System's PHAT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Phathom Pharmaceuticals (PHAT) in Q2 2021, closing a stake of 29,400 shares — an estimated $1.1M sold.

California Public Employees Retirement System first reported a position in PHAT in Q1 2020 and held it in 5 quarters. The position peaked at $1.2M in Q3 2020. 79 funds tracked by Wall St. Rank hold PHAT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Phathom Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 29,400 Phathom Pharmaceuticals shares in Q2 2021, an estimated $1.1M.
  • California Public Employees Retirement System first reported a position in Phathom Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • California Public Employees Retirement System's Phathom Pharmaceuticals position peaked at $1.2M in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.